ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 31 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $22,000 | -89.6% | 10,064 | -88.3% | 0.00% | -100.0% |
Q4 2020 | $212,000 | -37.6% | 85,654 | -25.4% | 0.01% | -58.3% |
Q2 2020 | $340,000 | -16.9% | 114,829 | -25.8% | 0.01% | -45.5% |
Q1 2020 | $409,000 | -47.6% | 154,658 | -1.5% | 0.02% | -38.9% |
Q4 2019 | $780,000 | -7.1% | 156,944 | +11.3% | 0.04% | -21.7% |
Q3 2019 | $840,000 | -6.0% | 141,012 | +1.8% | 0.05% | +4.5% |
Q2 2019 | $894,000 | -8.5% | 138,541 | -4.2% | 0.04% | -15.4% |
Q1 2019 | $977,000 | +64.5% | 144,583 | -0.9% | 0.05% | +23.8% |
Q4 2018 | $594,000 | – | 145,844 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|